INS and primary hyperparathyroidism: Kumar et al. [10] demonstrate that patients with primary hyperparathyroidism attain higher plasma glucose following an infusion compared to controls (p < 0.04), with 42% of patients with primary hyperparathyroidism having impaired glucose tolerance and lower insulin sensitivity (60.3%; p < 0.001).